Pyrimethamine Market: Trends, Forecast, and Competitive Analysis to 2030 Pyrimethamine Market Outlook 2022-2030: Pyrimethamine Market Growth size was estimated at USD 1,000 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% to reach approximately USD 1,650 million in 2030. Because pyrimethamine is resistant to many Plasmodium species, it is usually administered in conjunction with folinic acid and sulfa. The superoxide dismutase 1 gene, which codes for a protein associated with amyotrophic lateral sclerosis, has also been found to be inhibited by pyrimethamine. What is Pyrimethamine? Pyrimethamine is a folic acid antagonist that inhibits the dihydrofolate reductase enzyme, disrupting the reproduction of parasites such as Plasmodium (responsible for malaria) and Toxoplasma gondii. While its primary indication is for malaria, it is often prescribed alongside sulfadiazine and folinic acid for toxoplasmosis treatment. Get free access to sample report @ https://wemarketresearch.com/sample-request/pyrimethamine-market/867